Clinical Trials Browser

Unknown × Carcinoma × pemigatinib × Clear all

NCT05913661 2023-06-22

Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Digestive System Neoplasms, Cholangiocarcinoma